Vincerx Pharma Announces Stock Option Repricing and Shareholder Approval
PremiumCompany AnnouncementsVincerx Pharma Announces Stock Option Repricing and Shareholder Approval
3M ago
Vincerx Pharma 6M share Spot Secondary priced at 75c
Premium
The Fly
Vincerx Pharma 6M share Spot Secondary priced at 75c
7M ago
Vincerx Pharma offers to sell common stock, amount not stated
Premium
The Fly
Vincerx Pharma offers to sell common stock, amount not stated
7M ago
Vincerx Pharma presents preclinical VIP943, VIP924 posters at ASH 2023
PremiumThe FlyVincerx Pharma presents preclinical VIP943, VIP924 posters at ASH 2023
11M ago
Cantor biotech/biopharma analysts hold analyst/industry conference call
Premium
The Fly
Cantor biotech/biopharma analysts hold analyst/industry conference call
12M ago
Cantor biotech/biopharma analysts hold analyst/industry conference call
Premium
The Fly
Cantor biotech/biopharma analysts hold analyst/industry conference call
12M ago
Vincerx Pharma announces FDA clearance of IND for VIP943
PremiumThe FlyVincerx Pharma announces FDA clearance of IND for VIP943
1y ago
Vincerx Pharma expects cash to fund operations into late 2024
Premium
The Fly
Vincerx Pharma expects cash to fund operations into late 2024
1y ago
Vincerx Pharma reports Q2 EPS (52c), consensus (60c)
Premium
The Fly
Vincerx Pharma reports Q2 EPS (52c), consensus (60c)
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100